Inhibrx Biosciences Inc (INBX)
16.58
+0.58
(+3.62%)
USD |
NASDAQ |
Nov 12, 16:00
16.65
+0.07
(+0.42%)
After-Hours: 20:00
Inhibrx Biosciences Price: 16.58 for Nov. 12, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2024 | 16.03 | 17.41 | 15.86 | 16.58 | 130773.0 |
| Nov 11, 2024 | 16.32 | 16.60 | 15.97 | 16.00 | 56061.00 |
| Nov 08, 2024 | 16.15 | 16.63 | 15.97 | 16.21 | 79016.00 |
| Nov 07, 2024 | 16.16 | 16.68 | 16.16 | 16.26 | 68569.00 |
| Nov 06, 2024 | 16.79 | 16.79 | 15.58 | 16.05 | 95040.00 |
| Nov 05, 2024 | 15.61 | 15.71 | 15.24 | 15.71 | 33984.00 |
| Nov 04, 2024 | 15.66 | 15.85 | 15.41 | 15.55 | 28638.00 |
| Nov 01, 2024 | 16.24 | 16.49 | 15.65 | 15.80 | 38936.00 |
| Oct 31, 2024 | 16.32 | 16.34 | 16.00 | 16.03 | 35220.00 |
| Oct 30, 2024 | 16.14 | 16.44 | 16.02 | 16.29 | 49429.00 |
| Oct 29, 2024 | 16.00 | 16.43 | 15.94 | 16.10 | 37032.00 |
| Oct 28, 2024 | 15.64 | 16.30 | 15.64 | 16.00 | 46620.00 |
| Oct 25, 2024 | 15.57 | 15.78 | 15.34 | 15.37 | 26632.00 |
| Oct 24, 2024 | 15.71 | 15.89 | 15.30 | 15.37 | 21316.00 |
| Oct 23, 2024 | 15.66 | 15.87 | 15.32 | 15.76 | 33577.00 |
| Oct 22, 2024 | 15.50 | 16.00 | 15.31 | 15.80 | 28290.00 |
| Oct 21, 2024 | 15.84 | 15.93 | 15.50 | 15.50 | 20253.00 |
| Oct 18, 2024 | 16.21 | 16.25 | 15.82 | 16.00 | 38327.00 |
| Oct 17, 2024 | 16.12 | 17.02 | 15.85 | 16.17 | 83152.00 |
| Oct 16, 2024 | 16.02 | 16.13 | 15.63 | 16.05 | 91407.00 |
| Oct 15, 2024 | 15.55 | 16.20 | 15.46 | 15.74 | 71108.00 |
| Oct 14, 2024 | 15.66 | 15.80 | 15.49 | 15.50 | 51827.00 |
| Oct 11, 2024 | 15.50 | 15.64 | 15.31 | 15.64 | 83718.00 |
| Oct 10, 2024 | 15.66 | 15.77 | 15.37 | 15.58 | 83925.00 |
| Oct 09, 2024 | 16.00 | 16.20 | 15.45 | 15.67 | 106679.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
11.04
Minimum
Aug 09 2024
18.02
Maximum
Jun 03 2024
14.81
Average
15.18
Median
Sep 10 2024
Price Benchmarks
| CEL-SCI Corp | 0.7007 |
| AIM ImmunoTech Inc | 0.24 |
| IGC Pharma Inc | 0.3811 |
| NovaBay Pharmaceuticals Inc | 0.7801 |
| Protalix BioTherapeutics Inc | 1.32 |
Price Related Metrics
| PE Ratio | 0.143 |
| Price to Book Value | 1.094 |
| Earnings Yield | 699.2% |
| Market Cap | 240.01M |